Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cairo Univ. BACE1 compound 5a
- Development stage
- Unknown
- Lead developer
- Cairo University
01
Overview
Cairo Univ. BACE1 compound 5a: sourced facts only. name: "Collectively, N-phenylacetamide indole derivative bearing unsubstituted phenylhydrazinyl side chain 5a represents a promising multi-target candidate, combining AChE, BChE and BACE1 inhibition and can be considered as a lead compound for further development in AD therapy." [PMID:40449120]; target: "Collectively, N-phenylacetamide indole derivative bearing unsubstituted phenylhydrazinyl side chain 5a represents a promising multi-target candidate, combining AChE, BChE and BACE1 inhibition and can be considered as a lead compound for further development in AD therapy." [PMID:40449120]; developer: "Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. Electronic address: [email protected]." [PMID:40449120]
02
Targets
BACE1 (Beta-site APP-cleaving enzyme 1)
Beyond the preview
Go deeper on Cairo Univ. BACE1 compound 5a.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cairo Univ. BACE1 compound 5a.